Last week, the US
Food and Drug Administration approved lorcaserin (Belviq) to fight obesity, and
another fat-fighting drug may be approved later this month, but that doesn’t
mean you can rest easy, pop a pill, and forgo efforts to improve your diet and
activity levels.
“These drugs won’t
work without behavioral interventions,” said Dr. Caroline Apovian, director of
the nutrition and weight management center at Boston Medical
Center . Lorcaserin, in
particular, produced only modest weight loss -- about 5 percent on average --
in those who took the drug during clinical trials. That’s because some of the
initial weight loss was reversed in study participants who took the drug beyond
a year.
What’s more,
lorcaserin and other drugs to treat obesity are meant for, well, only those who
are truly obese -- which means they have at least 30 or more pounds to lose,
not 10 or 20. No one knows how well prescription drugs work if you just want to
shed an extra 10 or 20 pounds because the drugs haven’t been tested in those
who aren’t obese.
The American
Council on Exercise recommends that those who are obese consider prescription
drugs to be “a supplement to -- rather than a replacement for -- diet and
exercise”. Given that these drugs have possible side effects such as heart
risks, the rest of us would be better off reducing portion sizes, eating a low
glycemic index diet, and taking
more steps throughout the day.
No comments:
Post a Comment